Generic Ozempic Canada: Cost, Availability, and What to Expect

Generic Ozempic has arrived in Canada. Considering that an estimated three million Canadian adults are currently taking GLP-1 medications like Ozempic, this is a major development.

In late April 2026, Health Canada approved a generic version of semaglutide, the active ingredient in Ozempic. A second generic was approved days later, with seven more applications under review. At the time of the announcements, manufacturers said they expected to have cheaper Ozempic alternatives on pharmacy shelves within weeks.

This article covers everything Canadians need to know about generic Ozempic. We cover when you will be able to get it, what it will cost, and how Ozempic stacks up against other GLP-1 medications.

What Is Generic Ozempic?

Ozempic is the brand name for an injectable GLP-1 medication manufactured by Novo Nordisk. The active ingredient of Ozempic is a molecule called semaglutide. Generic Ozempic is that exact same molecule (semaglutide), manufactured by a different pharmaceutical company.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking a natural gut hormone that triggers insulin release, slows down digestion, and usually reduces appetite. Officially, semaglutide is prescribed as a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar. However, because it often produces weight loss in people who take it, doctors also prescribe semaglutide off-label for weight management.

To be approved by Health Canada, a generic drug must undergo rigorous testing to prove it is identical to the brand-name version. This means that generic semaglutide has the exact same active ingredient, dosage form (injectable), and safety profile as Ozempic. Going forward, generic versions of the medication will probably just be referred to as semaglutide, rather than generic Ozempic.

See our Ultimate Guide on Semaglutide for more detailed information on the molecule, side effects, and clinical uses.

Is Generic Ozempic Available in Canada?

Yes — though “approved” and “available on pharmacy shelves” are two slightly different things.

Health Canada approved the first generic version of semaglutide on April 28, 2026. This product comes from Dr. Reddy’s Laboratories. Three days later, on May 1, Apotex (Canada’s largest domestic drug manufacturer) became the second company to receive approval. Apotex said they expect their product to be physically available on pharmacy shelves within a couple of weeks.

The Dr. Reddy’s and Apotex generic semaglutide products are approved by Health Canada for the exact same use as branded Ozempic: a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar levels. However, just like the brand-name version, doctors can also prescribe these generics off-label for weight management. Because weight loss prescriptions are rarely covered by public drug plans, this cheaper generic alternative is exactly what many Canadians paying out of pocket have been waiting for.

Seven additional applications are currently under Health Canada review, including filings from: 

• Zydus Lifesciences
• Aspen Pharmacare Canada
• Sandoz
• Teva
• Taro Pharmaceuticals

Health Canada has indicated that decisions on these remaining submissions are expected in the coming weeks and months.

Why Canada Got Generic Ozempic Early

Canada is the first major global economy to approve generic Ozempic because patent protection on semaglutide expired here years before it will elsewhere.

Novo Nordisk’s foundational patent on semaglutide lapsed in Canada in 2020, after the company missed a mandatory patent maintenance fee. Following that, the eight-year regulatory data exclusivity period ended on January 4, 2026, and a secondary patent covering the injectable formulation expired in March 2026.

Those expired patents opened the legal pathway for Health Canada to authorize generic versions of Ozempic. By contrast, the main US patent on semaglutide doesn’t expire until 2032, and similar patent protections persist across Europe and other major markets.

When Will Generic Ozempic Be Available in Canada?

This article on the generic Ozempic Canada 2026 rollout was published in early May, so by the time you’re reading it, the medication may already be available at your local pharmacy.

Apotex has stated their product is expected to be available within weeks of the May 1 approval. Dr. Reddy’s, having received its approval days earlier, has said launch preparations are well underway. Both manufacturers control their own production, which removes one of the typical bottlenecks in generic launches.

How the Switch to Generic Semaglutide Works

Once generic semaglutide is available at wholesale, provincial formularies and private insurers trigger mandatory generic substitution. In other words, pharmacists are required to dispense the cheaper generic in place of branded Ozempic on new and refill prescriptions, unless your prescribing doctor specifically writes “no substitution” with a clinical reason.

For most patients with active Ozempic prescriptions, this means you don’t need to do anything to get the generic version. When you next pick up your medication, you may simply receive generic semaglutide. Both Apotex and Dr. Reddy’s have designed pre-filled pens that closely match the experience of using branded Ozempic to make the transition seamless. 

As with any new generic launch, supply will scale up over time, so don’t be surprised if your pharmacy is still dispensing branded Ozempic in the early weeks while inventory turns over.

How Much Will Generic Ozempic Cost in Canada?

Currently, the list price for a four-week supply of branded Ozempic on the Ontario Drug Benefit formulary is $227.94 (before pharmacy markups and dispensing fees). For patients paying out of pocket without private insurance, the actual retail cost at the pharmacy counter typically falls between $300 and $450 per month.

Generic medications are significantly cheaper, but the price doesn’t drop all at once. In Canada, generic drug prices are governed by the pan-Canadian Pharmaceutical Alliance (pCPA), which uses a tiered system. As more generic competitors enter the market, the mandated price drops further.

How Generic Price Drops Work

For injectable drugs like semaglutide, the pCPA pricing tiers work as a percentage of the original branded price:

• Tier 1 (One generic manufacturer) – The price is capped at 75% of the brand price, eventually dropping to 55%.
• Tier 2 (Two generic manufacturers) – The mandated price drops to 50% of the brand reference price.
• Tier 3 (Three or more generic manufacturers) – The mandated price drops to 35% of the brand reference price.

What Canadians Will Actually Pay

Because Health Canada approved Dr. Reddy’s and Apotex’s generic Ozempic within days of each other, the Canadian market skipped Tier 1 and jumped straight to Tier 2.

Here is what the public drug plan pricing for generic semaglutide looks like right now, and where it is headed in the near future:

• Current Price (Two generics approved) – The maximum public plan price is approximately $114 per four-week supply.
• Future Price (Three+ generics approved) – Once Health Canada approves a third manufacturer (highly likely given the seven pending applications), the maximum public plan price will drop to around $80 per month.

Note: These figures represent public drug plan pricing. Your actual out-of-pocket retail price will vary based on your specific provincial coverage, your private insurance plan, and the dispensing fees and markups at your local pharmacy.

What If I Am Paying Out of Pocket for Generic Ozempic?

If you are prescribed generic semaglutide off-label for weight loss, public drug plans will not cover the cost. You will need to pay out of pocket (or use private insurance, if your plan allows it).

However, these generic price drops still directly benefit you. Because the baseline wholesale cost of the drug has been slashed, the retail price you pay at the pharmacy counter will drop proportionately.

While you won’t pay the exact $80 or $114 public plan price, your new out-of-pocket cost — even after pharmacy markups and dispensing fees are added — will be dramatically lower than the $300 to $450 per month that Canadians currently pay for branded Ozempic.

How Does Generic Ozempic Compare to Other GLP-1 Medications?

Three GLP-1 medications currently dominate the Canadian market: Ozempic, Wegovy, and Mounjaro. The differences between them can be a little confusing, especially because two of them are semaglutide-based drugs.

Ozempic vs. Wegovy (Both are Semaglutide)

Both Ozempic and Wegovy are brand names for the same active ingredient: semaglutide. The practical differences are the branding, what they are officially approved for in Canada, and the maximum dose the injection pens can deliver.

• Ozempic (Semaglutide up to 2.0 mg): This is the “diabetes dose.” At the highest 2.0 mg dose, clinical trials showed an average weight loss of 14 pounds (about 7% of body weight). While it may be slightly less potent than Wegovy, the arrival of generic versions means this will be the most affordable GLP-1 option in Canada by a wide margin.
• Wegovy (Semaglutide 2.4 mg): Wegovy is essentially a higher-strength formulation of Ozempic. The Wegovy pen allows for a slightly higher 2.4 mg dose, which pushed average weight loss to 14.9% of body weight in foundational clinical trials. For patients paying out of pocket, the question is whether that extra weight loss is worth paying hundreds of dollars more per month compared to generic Ozempic.

Mounjaro & Zepbound (Branded Tirzepatide)

Mounjaro and Zepbound are brand names for a dual-agonist GLP-1 drug called tirzepatide. Just like the Ozempic and Wegovy split, Mounjaro is tirzepatide branded for diabetes, while Zepbound is the same drug delivered at a higher dose and branded for weight loss.

Tirzepatide produces the highest weight loss seen in any available GLP-1 drug to date — an average of 20.9% of body weight at the highest dose. However, it remains brand-name only and is significantly more expensive than generic semaglutide.

Will There Be a Generic Wegovy or Rybelsus?

Wegovy and Rybelsus are both semaglutide-based medications. But just because generic Ozempic is here, that doesn’t automatically mean generic versions of other semaglutide products are available.

• Generic Wegovy – Health Canada has not yet approved any generic equivalent for the higher 2.4 mg dose of semaglutide found in Wegovy pens. It is unclear if any of the pending applications from manufacturers target this higher dose.
• Generic Rybelsus: The drug uses a proprietary absorption-enhancing technology called SNAC to allow the medicine to work as a tablet. The patents protecting this technology don’t expire in Canada until the 2030s.

Will Generic Ozempic Be Covered by Public Drug Plans?

For Type 2 diabetes, yes. Branded Ozempic is currently covered by every Canadian provincial public drug plan. Generic semaglutide will inherit those listings, but coverage criteria vary by province. 

For patients seeking Ozempic for weight loss, the picture is different. 

Currently, Canadian public drug plans do not cover any weight loss medications. This means that even if you get a prescription for an officially approved weight-loss drug like Wegovy or Zepbound, the public system will not cover it.

This lack of public coverage is exactly what makes the arrival of generic Ozempic so important. For Canadians paying out of pocket, the off-label use of cheaper generic semaglutide offers a much more affordable pathway to medically supported weight loss.

Side Effects and Safety of Generic Semaglutide

Because generic semaglutide is biologically identical to branded Ozempic, the side effect profile is exactly the same.

The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and fatigue. These tend to be most pronounced when you first start the medication or step up to a higher dose, and they typically ease as your body adjusts.

For a more detailed look at serious risks, dosing schedules, and what to expect when starting treatment, see our comprehensive Ozempic Canada guide.

Frequently Asked Questions About Generic Semaglutide

Is generic Ozempic the same as compounded semaglutide?

No, and this is a critical distinction. In Canada, pharmacies are not legally permitted to mass-produce compounded copies of commercially available drugs like Ozempic. Despite this, a “grey market” of compounded semaglutide exists through some medical spas and online retailers. These compounded products often use unapproved salt forms of the molecule and have not undergone Health Canada safety reviews.

Generic Ozempic, by contrast, is a heavily regulated pharmaceutical product. It has been formally approved by Health Canada through the exact same regulatory pathway as branded Ozempic, with a full bioequivalence and safety review.

Will generic Ozempic look different from brand-name Ozempic?

The pens may look slightly different. Both Apotex and Dr. Reddy’s have designed pre-filled pens that closely match the dosing and use experience of branded Ozempic. But the packaging, labelling, and device design will not be identical to the Novo Nordisk product.

Will generic Ozempic be approved for weight loss in Canada?

Not currently. Both approved generic semaglutide products are indicated for Type 2 diabetes management only. Wegovy is the version of semaglutide approved for chronic weight management in Canada, and Wegovy currently remains brand-only. Whether generic versions of the higher-dose Wegovy formulation will be approved in future depends on if manufacturers file for it and successfully clear Health Canada review.

Do I need a new prescription to get generic Ozempic? 

Usually not. If you have an active prescription for Ozempic, pharmacists in Canada are generally required to practice mandatory generic substitution. This means they will automatically dispense the cheaper generic version when you refill, unless your doctor has specifically written “no substitution” on your prescription.

Will my private insurance cover generic Ozempic for weight loss? 

It depends entirely on your specific plan. Just like public plans, many private insurers strictly limit semaglutide coverage to patients with Type 2 diabetes. However, if your private plan currently covers branded Ozempic for weight loss off-label, they will likely require you to switch to the cheaper generic version to maintain your coverage.

Generic Ozempic Canada: The Bottom Line

The arrival of generic Ozempic in Canada is fundamentally about accessibility. With prices set to drop by as much as 65%, the massive financial barrier to highly effective, medically supported weight loss is about to be drastically lowered for the millions of Canadians currently paying out of pocket.

However, weight management is a complex, highly individual medical journey, and GLP-1 medications are not one-size-fits-all. Whether you are wondering if generic semaglutide is right for you, or if you should be considering other options, the licensed physicians at Walk In can help. 

Book a virtual consultation today to discuss your weight loss treatment options with a Canadian doctor from the comfort of your home.

Speak With a Doctor Today About Weight Loss Treatment